Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 34

1.

Transcriptional and signaling regulation in neural crest stem cell-derived melanocyte development: do all roads lead to Mitf?

Hou L, Pavan WJ.

Cell Res. 2008 Dec;18(12):1163-76. doi: 10.1038/cr.2008.303. Review.

PMID:
19002157
[PubMed - indexed for MEDLINE]
2.

Melanocytes in development, regeneration, and cancer.

White RM, Zon LI.

Cell Stem Cell. 2008 Sep 11;3(3):242-52. doi: 10.1016/j.stem.2008.08.005. Review.

PMID:
18786412
[PubMed - indexed for MEDLINE]
Free Article
3.

Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression.

Ryu B, Kim DS, Deluca AM, Alani RM.

PLoS One. 2007 Jul 4;2(7):e594.

PMID:
17611626
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The tyrosinase enhancer is activated by Sox10 and Mitf in mouse melanocytes.

Murisier F, Guichard S, Beermann F.

Pigment Cell Res. 2007 Jun;20(3):173-84.

PMID:
17516925
[PubMed - indexed for MEDLINE]
5.

Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS, Testori A, Larue L, Goding CR.

Genes Dev. 2006 Dec 15;20(24):3426-39.

PMID:
17182868
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

MITF: master regulator of melanocyte development and melanoma oncogene.

Levy C, Khaled M, Fisher DE.

Trends Mol Med. 2006 Sep;12(9):406-14. Epub 2006 Aug 8. Review.

PMID:
16899407
[PubMed - indexed for MEDLINE]
7.

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R, Weber BL, Nathanson KL, Phillips DJ, Herlyn M, Schadendorf D, Dummer R.

Pigment Cell Res. 2006 Aug;19(4):290-302.

PMID:
16827748
[PubMed - indexed for MEDLINE]
8.

Distinct sets of genetic alterations in melanoma.

Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H, Cho KH, Aiba S, Bröcker EB, LeBoit PE, Pinkel D, Bastian BC.

N Engl J Med. 2005 Nov 17;353(20):2135-47.

PMID:
16291983
[PubMed - indexed for MEDLINE]
Free Article
9.

MITF and cell proliferation: the role of alternative splice forms.

Bismuth K, Maric D, Arnheiter H.

Pigment Cell Res. 2005 Oct;18(5):349-59.

PMID:
16162175
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J, Lee C, Wagner SN, Li C, Golub TR, Rimm DL, Meyerson ML, Fisher DE, Sellers WR.

Nature. 2005 Jul 7;436(7047):117-22.

PMID:
16001072
[PubMed - indexed for MEDLINE]
Free Article
11.

Mutant PIK3CA promotes cell growth and invasion of human cancer cells.

Samuels Y, Diaz LA Jr, Schmidt-Kittler O, Cummins JM, Delong L, Cheong I, Rago C, Huso DL, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE.

Cancer Cell. 2005 Jun;7(6):561-73.

PMID:
15950905
[PubMed - indexed for MEDLINE]
Free Article
12.

Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression.

Carreira S, Goodall J, Aksan I, La Rocca SA, Galibert MD, Denat L, Larue L, Goding CR.

Nature. 2005 Feb 17;433(7027):764-9.

PMID:
15716956
[PubMed - indexed for MEDLINE]
13.

MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A.

Loercher AE, Tank EM, Delston RB, Harbour JW.

J Cell Biol. 2005 Jan 3;168(1):35-40. Epub 2004 Dec 28.

PMID:
15623583
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Melanocytes and the microphthalmia transcription factor network.

Steingrímsson E, Copeland NG, Jenkins NA.

Annu Rev Genet. 2004;38:365-411. Review.

PMID:
15568981
[PubMed - indexed for MEDLINE]
15.

Direct interaction of Sox10 with the promoter of murine Dopachrome Tautomerase (Dct) and synergistic activation of Dct expression with Mitf.

Jiao Z, Mollaaghababa R, Pavan WJ, Antonellis A, Green ED, Hornyak TJ.

Pigment Cell Res. 2004 Aug;17(4):352-62.

PMID:
15250937
[PubMed - indexed for MEDLINE]
16.
17.

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

Omholt K, Platz A, Kanter L, Ringborg U, Hansson J.

Clin Cancer Res. 2003 Dec 15;9(17):6483-8.

PMID:
14695152
[PubMed - indexed for MEDLINE]
Free Article
18.

Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression.

Omholt K, Karsberg S, Platz A, Kanter L, Ringborg U, Hansson J.

Clin Cancer Res. 2002 Nov;8(11):3468-74.

PMID:
12429636
[PubMed - indexed for MEDLINE]
Free Article
19.

Mutations of the BRAF gene in human cancer.

Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, Hargrave D, Pritchard-Jones K, Maitland N, Chenevix-Trench G, Riggins GJ, Bigner DD, Palmieri G, Cossu A, Flanagan A, Nicholson A, Ho JW, Leung SY, Yuen ST, Weber BL, Seigler HF, Darrow TL, Paterson H, Marais R, Marshall CJ, Wooster R, Stratton MR, Futreal PA.

Nature. 2002 Jun 27;417(6892):949-54. Epub 2002 Jun 9.

PMID:
12068308
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk